A detailed history of Park Place Capital Corp transactions in Novartis Ag stock. As of the latest transaction made, Park Place Capital Corp holds 152 shares of NVS stock, worth $15,666. This represents 0.01% of its overall portfolio holdings.

Number of Shares
152
Previous 794 80.86%
Holding current value
$15,666
Previous $84,000 79.76%
% of portfolio
0.01%
Previous 0.03%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$106.13 - $120.89 $68,135 - $77,611
-642 Reduced 80.86%
152 $17,000
Q2 2024

Jul 02, 2024

SELL
$92.57 - $107.37 $81,369 - $94,378
-879 Reduced 52.54%
794 $84,000
Q1 2024

Apr 18, 2024

SELL
$95.27 - $108.47 $74,786 - $85,148
-785 Reduced 31.94%
1,673 $161,000
Q4 2023

Jan 24, 2024

SELL
$92.27 - $101.54 $102,604 - $112,912
-1,112 Reduced 31.15%
2,458 $248,000
Q3 2023

Oct 17, 2023

BUY
$94.73 - $105.13 $1,231 - $1,366
13 Added 0.37%
3,570 $363,000
Q2 2023

Aug 04, 2023

SELL
$92.52 - $104.91 $46,074 - $52,245
-498 Reduced 12.28%
3,557 $358,000
Q1 2023

May 02, 2023

BUY
$80.03 - $92.81 $8,483 - $9,837
106 Added 2.68%
4,055 $373,000
Q4 2022

Feb 14, 2023

BUY
$75.55 - $92.52 $298,346 - $365,361
3,949 New
3,949 $358,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Park Place Capital Corp Portfolio

Follow Park Place Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Place Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Park Place Capital Corp with notifications on news.